The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this report. Certain information contained
in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Overview
We were formed on February 19, 2021 for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or more target
businesses. Our efforts to identify a prospective target business will not be
limited to any particular industry or geographic region. We intend to utilize
cash derived from the proceeds of the IPO in effecting our initial business
combination.
We are an emerging growth company and, as such, we are subject to all of the
risks associated with emerging growth companies.
We presently have no revenue. All activities for the period from February 19,
2021 (inception) through December 31, 2022 relate to the formation and the IPO
and seeking of a target business. We will have no operations other than the
active solicitation of a target business with which to complete a business
combination, and we will not generate any operating revenue until after the
Company's initial business combination, at the earliest. We will have
non-operating income in the form of interest income on cash and cash equivalents
from the proceeds derived from the IPO.
On March 11, 2022, we consummated the IPO of 6,900,000 Public Units, which
includes the full exercise of the over-allotment option by the underwriter in
the IPO, at a price of $10.00 per Public Unit, generating gross proceeds of
$69,000,000. Simultaneously with the closing of the IPO, we consummated the sale
of 351,500 Private Units, at a price of $10.00 per Private Unit, in a private
placement to our sponsor, generating gross proceeds of $3,515,000.
Upon the consummation of the IPO and the underwriter's full exercise of the
over-allotment option, and associated private placements, $70,035,000 of cash
was placed in the Trust Account. This amount equals 6,900,000 ordinary shares
subject to possible redemption multiplied by redemption value of $10.15 per
share.
As indicated in the accompanying consolidated financial statements, as of
December 31, 2022, we had $44,918 in cash held outside our Trust Account
available for working capital purposes.
On September 9, 2022, we entered into a merger agreement (the "Merger
Agreement") with certain parties aiming to acquire 100% of the equity securities
of Nature's Miracle, Inc. ("Nature's Miracle").
On November 14, 2022, LBBB Merger Corp., the Company's wholly owned subsidiary,
filed a Form S-4 containing the registration statement with respect to the
proposed business combination with Nature's Miracle.
On December 28, 2022, LBBB Merger Corp. filed a Form S-4/A containing amendment
No. 1 to the registration statement to address comments LBBB Merger Corp.
received from the SEC on December 14, 2022, regarding the registration
statement.
On January 20, 2023, LBBB Merger Corp. filed a Form S-4/A containing amendment
No. 2 to the registration statement to address comments LBBB Merger Corp.
received from the SEC on January 12, 2023.
On February 10, 2023, the Company issued an unsecured promissory note in the
aggregate principal amount of $100,000 to RedOne Investment Limited, the
Company's sponsor. The principal shall be payable promptly on the earlier date
on which either the Company consummates an initial business combination or has
received financing from other parties with no interest accrued, and the amount
of $100,000 does not have the conversion feature of converting into additional
Private Units, based on the description of the promissory note.
On March 9, 2023, we held an Extraordinary General Meeting (the "General
Meeting") of shareholders. In the General Meeting, shareholders approved to
amend our Amended and Restated Memorandum and Articles of Association (the
"Charter Amendment"), and to extend the time for us to complete a business
combination for an additional three (3) months, from March 11, 2023 to June 11,
2023 (the "Extension"). The amended Charter Amendment was filed with the
Registrar of companies in the Cayman Islands on March 10, 2023 and was effective
on that date. In connection with the approval of the Extension, we deposited
into the Trust Account $250,000 in accordance with the terms of the Charter
Amendment. In connection with the General Meeting, shareholders elected to
redeem a total of 2,767,411 ordinary shares. An aggregate payment of $28,707,673
was distributed from the Company's Trust Account because of this redemption.
On March 10, 2023, we entered into a loan agreement as the borrower with a third
party lender, our sponsor and Nature's Miracle Inc. ("NMI") as the guarantors.
The principal amount was $250,000 with no interest bearing and was repayable on
or before June 11, 2023 (the "Repayment Date"). We shall cause to issue 25,000
bonus shares to the lender of the surviving company when completing the proposed
business combination with NMI, no later than the Repayment Date.
On March 28, 2023, the Company issued an unsecured promissory note in the
aggregate principal amount of $100,000 to RedOne Investment Limited, the
Company's sponsor. The principal shall be payable promptly on the earlier date
on which either the Company consummates an initial business combination or has
received financing from other parties with no interest accrued, and the amount
of $100,000 does not have the conversion feature of converting into additional
Private Units, based on the description of the promissory note.
8
We cannot assure you that our plans to complete our initial business combination
will be successful. If we are unable to complete our initial business
combination within 15 months from the date of the IPO, we will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than five business days thereafter, redeem 100% of the
outstanding public shares and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the remaining holders of ordinary
shares and our board of directors, liquidate and dissolve. In the event of
liquidation, the holders of the founder shares and Private Units will not
participate in any redemption distribution with respect to their founder shares
or Private Units, until all of the claims of any redeeming shareholders and
creditors are fully satisfied (and then only from funds held outside the Trust
Account).
Results of Operations
Our entire activity from February 19, 2021 (inception) up to the consummation of
the IPO was in preparation for the IPO. Since the IPO, our activity has been
limited to the evaluation of business combination candidates, and we will not be
generating any operating revenues until the closing and completion of our
initial business combination. We expect to generate small amounts of
non-operating income in the form of interest income on cash and marketable
securities held in Trust Account. We will incur expenses as a result of being a
public company (for legal, financial reporting, accounting and auditing
compliance), as well as for consummating the proposed business combination.
For the year ended December 31, 2022, we had a net income of $253,602. We
incurred $754,524 of general and administrative expenses and earned $1,008,126
of interest income from investments in our Trust Account.
For the period from February 19, 2021 (inception) to December 31, 2021, we had a
net loss of $85,388, which consisted of $85,388 in formation, general and
administrative expenses.
Liquidity and Capital Resources
As of December 31, 2022, we had $44,918 in cash held outside our Trust Account
available for our working capital purposes.
Prior to the consummation of the IPO, our liquidity needs had been satisfied
through a payment from the sponsor of $25,000 for the founder shares, the loan
under an unsecured promissory note from the sponsor of $500,000. The promissory
note from the sponsor was converted into part of the subscription of $3,515,000
private placement on March 11, 2022.
Upon the consummation of the IPO and underwriter's full exercise of
over-allotment option on March 11, 2022, and associated private placements,
$70,035,000 of cash was placed in the Trust Account. As of December 31, 2022, an
aggregate of $71,043,126 was held in the Trust Account in money market funds
that invest in cash, U.S. Treasury Bills, notes, and other obligations issued or
guaranteed as to principal and interest by the U.S. Treasury.
In order to meet its working capital needs following the consummation of the
IPO, the Company's initial shareholders, officers and directors or their
affiliates may, but are not obligated to, loan the Company funds, from time to
time or at any time, in whatever amount they deem reasonable in their sole
discretion. Each working capital loan would be evidenced by a promissory note
and would either be paid upon consummation of the Company's initial business
combination, without interest, or, at the lender's discretion, up to certain
amount of the working capital loan may be converted upon consummation of the
Company's business combination into additional private units at a price of
$10.00 per unit. If the Company does not complete a business combination, the
working capital loan will only be repaid with funds not held in the Trust
Account and only to the extent available (see Note 5 of the Notes to the
Financial Statements included in this report). To date, an aggregate principal
amount of $200,000 was outstanding and evidenced by an unsecured promissory note
issued to RedOne Investment Limited, the Company's sponsor. The principal shall
be payable promptly on the earlier date on which either the Company consummates
an initial business combination or has received financing from other parties
with no interest accrued, and the amount of $200,000 does not have the
conversion feature of converting into additional private units, based on the
description of the promissory note.
In addition, an aggregate principal amount of $250,000 under a loan agreement
with a third party lender was outstanding as of the date this report was issued.
The loan is guaranteed by the Company's sponsor and Nature's Miracle Inc.
("NMI") with no interest bearing and is repayable on or before June 11, 2023
(the "Repayment Date"). The Company shall cause to issue 25,000 bonus shares to
the lender of the surviving company when completing the proposed business
combination with NMI, no later than the Repayment Date. The amount of $250,000
was deposited into the Company's Trust Account in accordance with the term of
the Company's Amended and Restated Memorandum and Articles of Association (the
"Charter Amendment").
Based on the foregoing, management believes that we will have sufficient working
capital and borrowing capacity to meet our needs through the earlier of the
consummation of a business combination or one year from this filing. Over this
time period, we will be using these funds for paying existing accounts payable,
staying as a public company and consummating the business combination.
If our estimates of the working capital needs are less than the actual amount
necessary to do so, we may have insufficient funds available to operate our
business prior to our initial business combination. Moreover, we may need to
obtain additional financing either to consummate our initial business
combination or because we become obligated to convert a significant number of
our public shares upon consummation of our initial business combination, in
which case we may issue additional securities or incur debt in connection with
such business combination. Subject to compliance with applicable securities
laws, we would only consummate such financing simultaneously with the
consummation of our initial business combination. Following our initial business
combination, if cash on hand is insufficient, we may need to obtain additional
financing in order to meet our obligations.
9
We performed an assessment on the Company's ability to continue as a going
concern in accordance with Financial Accounting Standard Board's Accounting
Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an
Entity's Ability to Continue as a Going Concern". There is no assurance that we
will be able to consummate the initial business combination within 15 months
from the date of the IPO. In the event that we fail to consummate business
combination within the required period, we will face mandatory liquidation and
dissolution subject to certain obligations under applicable laws or regulations.
This uncertainty raises substantial doubt about our ability as a going concern
one year from the date the financial statement is issued. No adjustments have
been made to the carrying amounts of assets or liabilities regarding the
possibility of us not continuing as a going concern, as a result of failing to
consummate business combination within 15 months from the date of the IPO.
Management plans to continue its efforts to consummate a business combination
within 15 months from the date of the IPO.
Critical Accounting Policies
Management's discussion and analysis of our results of operations and liquidity
and capital resources are based on our audited financial information. We
describe our significant accounting policies in Note 2 - Significant Accounting
Policies, of the Notes to Financial Statements included in this report. The
preparation of our consolidated financial statements in conformity with GAAP
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the consolidated financial statements. Judgments are
based on historical experience, terms of existing contracts, industry trends and
information available from outside sources, as appropriate. However, by their
nature, judgments are subject to an inherent degree of uncertainty, and,
therefore, actual results could differ from our estimates.
Offering Costs Associated with the IPO
Offering costs consist of underwriting, legal, accounting, registration and
other expenses incurred through the balance sheet date that are directly related
to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount
was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred
underwriting commissions, and $1,819,686 of other offering costs (which includes
$1,262,250 of representative shares, as described in Note 8 of the Notes to the
Financial Statements included in this report). The Company complies with the
requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin ("SAB")
Topic 5A - "Expenses of Offering". Offering costs were charged to shareholders'
equity upon the completion of the IPO. The Company allocates offering costs
between public shares, public warrants and public rights based on the estimated
fair values of them at the date of issuance. Accordingly, $5,109,364 was
allocated to public shares and was charged to temporary equity, and a sum of
$505,322 was allocated to public warrants and public rights, and was charged to
shareholders' equity.
Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in
accordance with the guidance in FASB ASC Topic 480 "Distinguishing Liabilities
from Equity." Ordinary shares subject to mandatory redemption (if any) are
classified as a liability instrument and are measured at fair value.
Conditionally redeemable ordinary shares (including ordinary shares that feature
redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within the
Company's control) are classified as temporary equity. At all other times,
ordinary shares are classified as shareholders' equity. The Company's public
shares feature certain redemption rights that are considered to be outside of
the Company's control and subject to occurrence of uncertain future events. The
Company recognizes changes in redemption value immediately as they occur and
adjusts the carrying value of redeemable ordinary shares to equal the redemption
value at the end of each reporting period. Increases or decreases in the
carrying amount of redeemable ordinary shares are affected by charges against
additional paid in capital or accumulated deficit if additional paid in capital
equals to zero. Accordingly, as of December 31, 2022, ordinary shares subject to
possible redemption are presented at redemption value of $10.296 per share as
temporary equity, outside of the shareholders' equity section of the Company's
balance sheet.
Net Income (Loss) per Share
We comply with accounting and disclosure requirements of FASB ASC 260, Earnings
Per Share. In order to determine the net income (loss) attributable to both the
redeemable shares and non-redeemable shares, the Company first considered the
undistributed income (loss) allocable to both the redeemable shares and
non-redeemable shares and the undistributed income (loss) is calculated using
the total net loss less any dividends paid. We then allocated the undistributed
income (loss) ratably based on the weighted average number of shares outstanding
between the redeemable and non-redeemable shares. Any remeasurement of the
accretion to redemption value of the ordinary shares subject to possible
redemption was considered to be dividends paid to the public shareholders.
10
For the year ended December 31, 2022 and for the period from February 19, 2021
(inception) to December 31, 2021, the Company did not have any dilutive
securities and other contracts that could, potentially, be exercised or
converted into ordinary shares and then share in the earnings of the Company. As
a result, diluted loss per share is the same as basic loss per share for the
period presented. The calculation of diluted loss per share does not consider
the effect of the warrants issued in connection with the IPO and the private
placement since the exercise of warrants are contingent on the occurrence of
future events.
Warrants
The Company evaluates the public and private warrants as either
equity-classified or liability-classified instruments based on an assessment of
the warrants' specific terms and applicable authoritative guidance in Financial
Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC")
480, Distinguishing Liabilities from Equity ("ASC 480") and ASC 815, Derivatives
and Hedging ("ASC 815"). The assessment considers whether the warrants are
freestanding financial instruments pursuant to ASC 480, meet the definition of a
liability pursuant to ASC 480, and whether the warrants meet all of the
requirements for equity classification under ASC 815, including whether the
warrants are indexed to the Company's own ordinary shares, among other
conditions for equity classification. Pursuant to such evaluation, both public
and private warrants are classified in shareholders' equity.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on our
consolidated financial statements.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of December 31, 2022. We do not participate in
transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or purchased any non-financial assets.
Contractual Obligations
Underwriting Agreement
A deferred underwriting commission of $0.35 per Public Unit sold, totaling
$2,415,000 will be payable to the underwriters from the amounts held in the
Trust Account solely in the event that the Company completes a business
combination, without accrued interest. In the event that the Company does not
close a business combination, the representative underwriter forfeits its right
to receive the commission.
Registration Rights
The initial shareholders will be entitled to registration rights with respect to
their initial shares, as well as the holders of the Private Units and holders of
any securities issued to the Company's initial shareholders, officers, directors
or their affiliates in payment of working capital loans or extension loans made
to the Company, will be entitled to registration rights with respect to the
Private Units (and underlying securities), pursuant to an agreement signed on
the effective date of the IPO. The holders of such securities are entitled to
demand that the Company register these securities at any time after the Company
consummates a business combination. In addition, the holders have certain
"piggy-back" registration rights on registration statements filed after the
Company's consummation of a business combination.
Engagement agreement with Legal Counsel
The Company has entered into an engagement agreement with its legal counsel with
respect to the proposed business combination. The fee will be based on the
number of hours spent. An aggregate of $200,000 will be paid before the closing
of the business combination and the balance will be due upon the closing of the
business combination. As of December 31, 2022, an aggregate of $250,000 had been
accrued into the Company's consolidated financial statements.
Engagement agreement with Underwriter
The Company has entered into an engagement agreement with its underwriter with
respect to the proposed business combination. A success fee will be paid upon
closing of the business combination, with the amount calculated as the following
schedule: (i) 2% of the aggregate value of transaction (as described in Note 1,
Business Combination) for the part up to $200 million; (ii) 1% for the part over
$200 million.
11
Engagement Agreement - Fairness Opinion
An aggregate of $90,000 will be paid upon the closing of the business
combination, based on an engagement agreement entered into by the Company and
the provider of fairness opinion concerning the terms of the business
combination.
© Edgar Online, source Glimpses